Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))

Ki Cheong Park; Seok Mo Kim; Jeong Yong Jeon; Bup Woo Kim; Hyeung Kyoo Kim; Ho Jin Chang; Yong Sang Lee; Soo Young Kim; Seung Hoon Choi; Cheong Soo Park; Hang Seok Chang

doi:10.1016/j.neo.2017.05.006

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))

Ki Cheong Park, Seok Mo Kim, Jeong Yong Jeon, Bup Woo Kim, Hyeung Kyoo Kim, Ho Jin Chang, Yong Sang Lee, Soo Young Kim, Seung Hoon Choi, Cheong Soo Park, Hang Seok Chang

Department of Surgery

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors discovered an error in Figure 3A. The band for Apaf-1 in Figure 3A was inserted in reversed manner and is presented correctly below.

Original language	English
Pages (from-to)	660
Number of pages	1
Journal	Neoplasia (United States)
Volume	19
Issue number	8
DOIs	https://doi.org/10.1016/j.neo.2017.05.006
Publication status	Published - 2017 Aug

Bibliographical note

Publisher Copyright:
© 2017 The Authors

All Science Journal Classification (ASJC) codes

Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.neo.2017.05.006

Fingerprint

Dive into the research topics of 'Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))'. Together they form a unique fingerprint.

Cite this

Park, K. C., Kim, S. M., Jeon, J. Y., Kim, B. W., Kim, H. K., Chang, H. J., Lee, Y. S., Kim, S. Y., Choi, S. H., Park, C. S., & Chang, H. S. (2017). Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005)). Neoplasia (United States), 19(8), 660. https://doi.org/10.1016/j.neo.2017.05.006

@article{773eb72b8775471cba442d4f7c5264ff,

title = "Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))",

abstract = "The authors discovered an error in Figure 3A. The band for Apaf-1 in Figure 3A was inserted in reversed manner and is presented correctly below.",

author = "Park, {Ki Cheong} and Kim, {Seok Mo} and Jeon, {Jeong Yong} and Kim, {Bup Woo} and Kim, {Hyeung Kyoo} and Chang, {Ho Jin} and Lee, {Yong Sang} and Kim, {Soo Young} and Choi, {Seung Hoon} and Park, {Cheong Soo} and Chang, {Hang Seok}",

note = "Publisher Copyright: {\textcopyright} 2017 The Authors",

year = "2017",

month = aug,

doi = "10.1016/j.neo.2017.05.006",

language = "English",

volume = "19",

pages = "660",

journal = "Neoplasia (United States)",

issn = "1522-8002",

publisher = "Elsevier Inc.",

number = "8",

}

Park, KC, Kim, SM, Jeon, JY, Kim, BW, Kim, HK, Chang, HJ, Lee, YS, Kim, SY, Choi, SH, Park, CS & Chang, HS 2017, 'Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))', Neoplasia (United States), vol. 19, no. 8, pp. 660. https://doi.org/10.1016/j.neo.2017.05.006

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005)). / Park, Ki Cheong; Kim, Seok Mo; Jeon, Jeong Yong et al.
In: Neoplasia (United States), Vol. 19, No. 8, 08.2017, p. 660.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))

AU - Park, Ki Cheong

AU - Kim, Seok Mo

AU - Jeon, Jeong Yong

AU - Kim, Bup Woo

AU - Kim, Hyeung Kyoo

AU - Chang, Ho Jin

AU - Lee, Yong Sang

AU - Kim, Soo Young

AU - Choi, Seung Hoon

AU - Park, Cheong Soo

AU - Chang, Hang Seok

PY - 2017/8

Y1 - 2017/8

N2 - The authors discovered an error in Figure 3A. The band for Apaf-1 in Figure 3A was inserted in reversed manner and is presented correctly below.

AB - The authors discovered an error in Figure 3A. The band for Apaf-1 in Figure 3A was inserted in reversed manner and is presented correctly below.

UR - http://www.scopus.com/inward/record.url?scp=85022021550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022021550&partnerID=8YFLogxK

U2 - 10.1016/j.neo.2017.05.006

DO - 10.1016/j.neo.2017.05.006

M3 - Comment/debate

C2 - 28739012

AN - SCOPUS:85022021550

SN - 1522-8002

VL - 19

SP - 660

JO - Neoplasia (United States)

JF - Neoplasia (United States)

IS - 8

ER -

Park KC, Kim SM, Jeon JY, Kim BW, Kim HK, Chang HJ et al. Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005)). Neoplasia (United States). 2017 Aug;19(8):660. doi: 10.1016/j.neo.2017.05.006

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153], (S1476558616302640), (10.1016/j.neo.2016.12.005))

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this